Does Bill Clinton Have Hiv/Aids? I Ask The Question No One Else Will

Bill Clinton

This question has been asked by many people over the years. We look at former President William Jefferson Clinton & wonder why age hasn’t been his friend? We also ask with the news of his promiscuous life is he infected with the Virus?

I ask the tough questions no one else will!

Bill & Hillary have been very active with lowering the costs of HIV/Aids medications for citizens of the world. My question is why now? Does Bill know something we don’t and he’s trying to lower the costs before it completly takes over his life? They’re going broke due to Hillary losing in 2016. No one believes in her or her message anymore and have stopped donating to the Clinton Foundation.

“I’m proud of the work that it has done,” Clinton said in the June 8, 2016, interview. “Nine million people have lower-cost HIV/AIDS medicine because of the work of the Clinton Foundation and my husband. We have women across the country, from Latin America and Africa — across the world, I mean — getting good jobs, and being able to support themselves for the first time.”

We’ll focus on the first part of that statement and explore if the Clinton Foundation actually had a hand in making HIV/AIDS drugs more affordable for 9 million people?

The foundation’s work on HIV/AIDS treatment dates back to 2002 with the creation of the Clinton Health Access Initiative. That was a time when some countries were paying $1,000 or more to treat each AIDS patient. The basic goal was to bring in bulk-buying to lower costs.

When President Clinton was in the Oval office he didn’t do much of anything for the cause. The LGBTQ community often asked when is President Clinton going to help them instead of leaving them to die.

Although he did put some sort of money towards the research, initially there was nothing new discovered nor did they fight after the money ran out.


Washington, DC – This evening, President Donald Trump announced a bold
initiative to “End the HIV Epidemic” by 2030 in the United States as part of his
State of the Union address.
“President Trump is taking a bold step to design an innovative program and
strategy, and commit new resources, to end HIV in the United States. His
proposal to increase access to antiretroviral medications for people living with
HIV and for prevention in those communities with the highest rates of HIV and
where additional resources are most needed will translate into fewer HIV
infections. Under the President’s proposal, the number of new infections can
eventually be reduced to zero,” commented Carl Schmid, Deputy Executive
Director of The AIDS Institute. Schmid is also Co-Chair of the President’s Advisory
Council on HIV/AIDS (PACHA).
“While we might have policy differences with the President and his
Administration, this initiative, if properly implemented and resourced, can go
down in history as one of the most significant achievements of his Presidency,”
stated The AIDS Institute’s Executive Director, Michael Ruppal. “We look forward
to learning more details of his plan, including its proposed budget, and will work
together with the HIV community and state and local governments on its
implementation. Before that can happen, though, Congress first must support its
funding. Addressing HIV/AIDS at home and abroad has always been supported
in a bipartisan manner, and we expect that to continue as this proposal is
The first reported case of AIDS in the United States was in 1981. Since then, more
than 700,000 people with AIDS have died in the U.S. Today, there are over 1.1
million people living with HIV and nearly 40,000 new diagnoses each year. While
there is no cure, if people are adherent to a daily regimen of antiretroviral
medications, they can live a relatively long and healthy life, and the virus can
become suppressed to such a level that it cannot be transmitted. Therefore,
treatment is also prevention. However, only half of all people living with HIV are
virally suppressed.
There are other proven methods of HIV prevention, including condoms, syringe
service programs, and now, an FDA approved drug that acts as a Pre-exposure
Prophylaxis (PrEP), that if taken daily prevents HIV. The initiative announced by
President Trump includes a scale up of HIV testing, treatment and prevention,
including PrEP, in the communities most impacted by HIV and in need of
increased resources.
HIV has disproportionately impacted certain communities, including gay men,
black women and men, and injection drug users. The highest new diagnoses
today are occurring among young black and Latino gay men, followed by
white gay men and black heterosexual women. Over half of all new diagnoses
are in the South; 56 percent of new diagnoses are among people under 35; and
43 percent of new diagnoses are African Americans although they account for
only 13 percent of the population.
HIV prevention in the U.S. is led by the Centers for Disease Control and
Prevention (CDC), AIDS research at the National Institutes of Health (NIH), and
HIV treatment is financed by Medicaid, Medicare, private insurance and the
Ryan White HIV/AIDS Program at Health Resources and Services Administration
(HRSA). The Ryan White Program currently provides some level of health care,
medications and support services to approximately one half of all people
diagnosed with HIV in the U.S. Its patient focused system of care is credited with
achieving an 86 percent viral suppression rate among its clients.
The initiative announced by the President builds upon these existing public
health programs and was developed with the expertise of the heads of these
agencies under the leadership of HHS Secretary Alex Azar and Assistant
Secretary of Health Brett Giroir.

The Aids Institute
Ethan Sabo

Author: Ethan Sabo

Openly Gay Conservative Republican Stomping The Stereotype! Fighting For Freedom & Against Political Correctness!

Leave a Reply

Your email address will not be published. Required fields are marked *